Quick Takeaways
- Michael S. Gordon filed SCHEDULE 13G/A for ProMIS Neurosciences Inc. Common Shares, No Par Value (PMN).
- Disclosed ownership: 9%.
- Date of event: 30 Jun 2025.
Michael S. Gordon - 30 Jun 2025 SCHEDULE 13G/A Report for ProMIS Neurosciences Inc. Common Shares, No Par Value (PMN)
- Filing Manager
- Michael S. Gordon
- Reporting Manager
- Michael S. Gordon
- Symbol
- PMN
- Shares outstanding
- 54,290,089 shares
- Disclosed Ownership
- 4,886,108 shares
- Ownership
- 9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:20:09 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael S. Gordon disclosed 9% ownership in ProMIS Neurosciences Inc. Common Shares, No Par Value (PMN) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 16:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Michael S. Gordon | 9% | 4,886,108 | 0 | 4,886,108 | /s/ Michael S. Gordon | Self | |
| Title 19 Promis | 9% | 4,886,108 | 0 | 4,886,108 | /s/ Michael S. Gordon | Michael S. Gordon, Manager |